Ray E. Hershberger

Active 1988–2025

Also published as
Ray E Hershberger
93
Papers
22,396
Citations
72
h-index
90
i10-index

Citations

Citations per year for Ray E. Hershberger1967: 1 citations1971: 1 citations1983: 1 citations1989: 4 citations1990: 15 citations1991: 19 citations1992: 22 citations1993: 35 citations1994: 17 citations1995: 28 citations1996: 28 citations1997: 39 citations1998: 47 citations1999: 65 citations2000: 51 citations2001: 84 citations2002: 48 citations2003: 63 citations2004: 52 citations2005: 48 citations2006: 49 citations2007: 53 citations2008: 58 citations2009: 72 citations2010: 107 citations2011: 158 citations2012: 168 citations2013: 208 citations2014: 140 citations2015: 126 citations2016: 147 citations2017: 137 citations2018: 115 citations2019: 443 citations2020: 578 citations2021: 727 citations2022: 674 citations2023: 548 citations2024: 898 citations2025: 397 citations2026: 17 citations1968–1970: no citations, so these years are not shown1972–1982: no citations, so these years are not shown1984–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,396 citing papers, 27.2% of this breakdownUnited Kingdom: 711 citing papers, 8.1% of this breakdownItaly: 586 citing papers, 6.7% of this breakdownGermany: 527 citing papers, 6% of this breakdownNetherlands: 478 citing papers, 5.4% of this breakdownCanada: 385 citing papers, 4.4% of this breakdownAustralia: 334 citing papers, 3.8% of this breakdownChina: 325 citing papers, 3.7% of this breakdownFrance: 281 citing papers, 3.2% of this breakdownSpain: 253 citing papers, 2.9% of this breakdownJapan: 193 citing papers, 2.2% of this breakdownDenmark: 150 citing papers, 1.7% of this breakdown
0%27.2%Other 24.7%

Fields

  • Medicine69.1%
  • Biochemistry, Genetics and Molecular Biology26.3%
  • Engineering1.4%
  • Neuroscience0.8%
  • Immunology and Microbiology0.4%
  • Computer Science0.3%
  • Other1.7%

Topics

  • Cardiomyopathy and Myosin Studies8.8%
  • Cardiac electrophysiology and arrhythmias6.3%
  • Cardiovascular Effects of Exercise4.7%
  • Heart Failure Treatment and Management4.7%
  • Cardiovascular Function and Risk Factors3.9%
  • Genomics and Rare Diseases3.7%
  • Other67.9%

Coauthors

All papers

Open in search
  1. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 cited by 569

  2. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roddy Walsh, Jessica Wang, James S. Ware, Ray E. Hershberger - Circulation 2021 cited by 512

  3. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

    Authors: , , , , , , , , , , , , , - Genetics in Medicine 2023 cited by 417

  4. Dilated cardiomyopathy

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2019 cited by 674

  5. Dilated cardiomyopathy: the complexity of a diverse genetic architecture

    Authors: , , - Nature Reviews Cardiology 2013 cited by 1,013

  6. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation Genomic and Precision Medicine 2019 cited by 450

  7. Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , - Circulation Genomic and Precision Medicine 2020 cited by 372

  8. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

    Authors: , , , , , , , , , , , , , - Genetics in Medicine 2022 cited by 288

  9. Clinical Genetic Testing for Familial Hypercholesterolemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Ledbetter, Daniel J. Rader - Journal of the American College of Cardiology 2018 cited by 597

  10. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

    Authors: , , , , , , , , , , , , , , , , , - Genetics in Medicine 2021 cited by 562

  11. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 399

  12. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation Genomic and Precision Medicine 2021 cited by 234

  13. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

    Authors: , , , , , , , , , , , , , , , , , , , , - Heart Rhythm 2011 cited by 1,468

  14. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

    Authors: , , , , , , , , , , , , , , , , , - Genetics in Medicine 2021 cited by 263

  15. Reappraisal of Reported Genes for Sudden Arrhythmic Death

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2018 cited by 370

  16. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death

    Authors: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 cited by 143

  17. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Genetics in Medicine 2018 cited by 371

  18. ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene‐level specification of the ACMG/AMP guidelines for sequence variant interpretation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Human Mutation 2018 cited by 219

  19. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

    Authors: , , , , , , , , , - Genetics in Medicine 2018 cited by 283

  20. Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline

    Authors: , , , , , - Journal of Cardiac Failure 2009 cited by 705

  21. Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure

    Authors: , , , , , , , , , , , - Circulation 1996 cited by 1,306

  22. Effects of Danicamtiv, a Novel Cardiac Myosin Activator, in Heart Failure with Reduced Ejection Fraction: Experimental Data and Clinical Results from a Phase 2a Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 106

  23. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

    Authors: , , , , , , , , , , , , , , , , , , , , - EP Europace 2011 cited by 901

  24. Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2019 cited by 147